Author: ksandness

Medicines360 and DKT WomanCare Announce Strategic Partnership to Expand Access to the Hormonal IUD Avibela™

Medicines360 Appoints Lisa David as Chair of the Board of Directors, Strengthening its Commitment to Women’s Health

FDA Approves Medicines360’s Supplemental New Drug Application for LILETTA^® (levonorgestrel-releasing intrauterine system) 52 mg as Treatment of Heavy Menstrual Bleeding

Medicines360 Appoints Andrea Olariu, MD, PhD as Chief Executive Officer 

Medicines360 Applauds U.S. Congress for Enshrining Nonprofit Pharma in Federal Law for the First Time